Emerging Multimodality Approaches to Treat Localized Esophageal Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
Ronan J Kelly

Abstract

Esophageal cancer has a poor prognosis, with 5-year survival rates ranging from 20% to 35% in the nonmetastatic setting. Despite advances in surgical techniques and optimization of chemoradiotherapy regimens, overall survival benefits have been incremental at best. Esophageal cancer requires a concerted multidisciplinary approach, perhaps more so than any other tumor type given the integral role played by the esophagus in maintaining calorific intake and the propensity for early spread through the lymphatics. This review describes the latest in surgical techniques to minimize postoperative complications and examines previous and ongoing systemic therapy approaches. Strategies that harness a patient's own immune system hold great promise, and shifting checkpoint inhibitors from the metastatic setting to the neoadjuvant/adjuvant setting is currently being evaluated in phase II and III clinical trials. In addition, a much better understanding of the interplay between tumors and their immune microenvironment is clearly needed to better judge how best to engage each patient's immune system, and there will be likely demonstrable differences between early-stage tumors and metastatic disease. This review highlights emerging data, which...Continue Reading

References

Dec 31, 1998·The New England Journal of Medicine·D P KelsenJ A Roth
Jul 11, 2006·The New England Journal of Medicine·David Cunningham MAGIC Trial Participants
Aug 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David P KelsenUNKNOWN USA Intergroup
Jan 14, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael StahlHansjochen Wilke
Sep 23, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William H AllumRuth E Langley
Mar 30, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc YchouPhilippe Rougier
Jun 1, 2012·The New England Journal of Medicine·P van HagenUNKNOWN CROSS Group
May 9, 2014·International Journal of Clinical Oncology·Yiting GengChangping Wu
May 17, 2014·World Journal of Gastrointestinal Oncology·Kyle J NapierSubhasis Misra
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Jan 20, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F KlevebroM Nilsson
Oct 18, 2016·Annals of Surgery·Arnaud PasquerUNKNOWN FREGAT Working GroupFRENCH
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jun 20, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Michael StahlWilfried Budach
Jan 10, 2019·The New England Journal of Medicine·Christophe MarietteUNKNOWN Fédération de Recherche en Chirurgie (FRENCH) and French Eso-Gastric Tumors (FREGAT) Working Group

❮ Previous
Next ❯

Citations

Jul 8, 2020·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·G SheillE Guinan
Dec 4, 2021·Frontiers in Cellular and Infection Microbiology·Zongdan JiangShukui Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the National Comprehensive Cancer Network : JNCCN
Rosalyn A Juergens, Arlene Forastiere
Annals of the New York Academy of Sciences
Lucas GoenseRichard van Hillegersberg
Current Opinion in Gastroenterology
Nimish Vakil, Aboud Affi
© 2021 Meta ULC. All rights reserved